0001818382-22-000090.txt : 20220613
0001818382-22-000090.hdr.sgml : 20220613
20220613162124
ACCESSION NUMBER: 0001818382-22-000090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220609
FILED AS OF DATE: 20220613
DATE AS OF CHANGE: 20220613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Constantino Michael T.
CENTRAL INDEX KEY: 0001817285
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39532
FILM NUMBER: 221011885
MAIL ADDRESS:
STREET 1: C/O 9 METERS BIOPHARMA, INC.
STREET 2: 8480 HONEYCUTT ROAD, SUITE 120
CITY: RALEIGH
STATE: NC
ZIP: 27615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Humacyte, Inc.
CENTRAL INDEX KEY: 0001818382
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851763759
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919-313-9633
MAIL ADDRESS:
STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54
CITY: DURHAM
STATE: NC
ZIP: 27713
FORMER COMPANY:
FORMER CONFORMED NAME: Alpha Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20200716
4
1
wf-form4_165515166596398.xml
FORM 4
X0306
4
2022-06-09
0
0001818382
Humacyte, Inc.
HUMA
0001817285
Constantino Michael T.
2525 EAST NORTH CAROLINA HIGHWAY 54
DURHAM
NC
27713
1
0
0
0
Stock Options (right to buy)
4.34
2022-06-09
4
A
0
8500
0
A
2032-06-09
Common Stock
8500.0
8500
D
The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.
/s/ Michael T. Constantino by Dale A. Sander as Attorney-in-Fact
2022-06-13